Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs Sana Biotechnology, Inc. (SANA)

DBV Technologies S.A. and Sana Biotechnology, Inc. are both Biotechnology companies. DBV Technologies S.A. and Sana Biotechnology, Inc. are of similar size ($746.5M and $686.2M). Sana Biotechnology, Inc. has the higher net margin (0.00% vs −5,547.3%) and the lower return on invested capital (−178.5% vs 0.00%). Across the 14 metrics below, Sana Biotechnology, Inc. leads on 10 and DBV Technologies S.A. on 4.

Valuation

Metric DBVT SANA Biotechnology median
P/E n/m n/m 11.58
P/S 286.84 n/m 9.61
P/B 7.21 3.91 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 242.54 n/m 9.43
Earnings yield (26.00%) (23.04%) (32.28%)
Free cash flow yield (17.89%) (20.42%) (22.27%)

Profitability

Metric DBVT SANA Biotechnology median
Gross margin 100.00% 0.00% 68.81%
Operating margin (5,571.63%) 0.00% 0.00%
Net margin (5,547.30%) 0.00% 0.00%
Free cash flow margin (5,131.50%) 0.00% 0.00%
Return on equity (205.75%) (79.47%) (50.30%)
Return on assets (127.19%) (36.79%) (45.47%)
Return on invested capital 0.00% (178.50%) 0.00%

Growth

Metric DBVT SANA Biotechnology median
Revenue growth (TTM) (33.42%) — 6.78%
EPS growth (last fiscal year) 10.26% 17.24% 29.88%
Revenue growth, 5-year CAGR (12.95%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT SANA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.24 1.77 4.74
Net debt to EBITDA 1.35 0.60 1.01

Dividend

Metric DBVT SANA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric DBVT SANA Biotechnology median
Market cap 746.54m 686.16m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack